TRM Labs stock
Private-market facts for current and former TRM Labs employees researching their stock.
Overview
Blockchain intelligence platform that helps financial institutions and government agencies detect and investigate cryptocurrency fraud, money laundering, and sanctions evasion.
TRM Labs outlook
For employees evaluating TRM Labs equity, a 1x base multiple suggests the stock may be close to fairly valued at current prices. The upside scenario at 3x is relatively close to the base case, suggesting more predictable but narrower range of outcomes.
These estimates reflect modeled return scenarios, not guaranteed outcomes. Actual results depend on company performance, market conditions, share class, and timing.
Selling TRM Labs shares
Why shareholders consider selling
Shareholders in TRM Labs may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, TRM Labs does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.
Can you sell TRM Labs stock?
Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Blockchain & Web3 sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing TRM Labs shares would be outlined in the holder's equity agreement or the company's governing documents.
What affects the value of TRM Labs shares?
The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Blockchain & Web3 market conditions, and any recent private-market transaction activity. Data points such as the company's Series B round and its reported $1B valuation can help frame expectations, though they do not guarantee a transaction price.
What should holders check before selling
- The type of security held (common shares, preferred, options, RSUs)
- Whether the equity is fully vested and, for options, whether it has been exercised
- Any transfer restrictions, lock-up provisions, or company approval requirements
- Estimated net proceeds after applicable taxes and transaction fees
- Whether partial liquidity — selling a portion rather than the full position — may be a better fit
Tools for TRM Labs shareholders
Exploring equity in TRM Labs often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.
Latest funding round
TRM Labs most recently raised a Series B round in June 2023. The company was valued at $1B. Total funding raised to date is approximately $150M.
Lead investors in this round include Thoma Bravo and Goldman Sachs.
Founders & company background
TRM Labs was founded in 2018 by Esteban Castaño, Rahul Raina and is headquartered in San Francisco, CA.
Investors
Industry
Similar private companies
Latest TRM Labs news
Frequently asked questions
- Is TRM Labs still a private company?
- Yes, TRM Labs is currently a private company.
- What is TRM Labs's latest funding round?
- TRM Labs's most recent known round is Series B, raised in June 2023.
- What is TRM Labs's valuation?
- TRM Labs's latest reported valuation is $1B.
- Who are the investors in TRM Labs?
- Notable investors include Thoma Bravo, Goldman Sachs, PayPal Ventures, Citi Ventures.
- Can I sell my TRM Labs stock?
- Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands TRM Labs stock can help you evaluate your options.
Related pages
Last verified: 2026-04-13 · TRM Labs data compiled from funding disclosures, investor announcements, corporate filings, and public records.
Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.